LGND
Ligand Pharmaceuticals Incorporated
296.90$
-3.2%
vs. previous close
Closing price · As of: Oct 6, 2026
Statements
Cash Flow
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.44 | 0.40 | 1.03 | 0.74 | 1.98 | 1.50 | -1.33 | 0.79 | 0.65 | 2.17 | 2.45 | 1.10 | 6.03 | |
| 0.50 | 0.53 | 0.48 | 0.49 | 0.40 | 0.45 | 0.49 | 0.45 | 0.34 | 0.46 | 0.41 | 0.38 | 1.51 | |
| 0.40 | 0.32 | 0.40 | 0.61 | 1.42 | 0.40 | 0.41 | 0.50 | 0.73 | 0.68 | 0.53 | 0.63 | 2.44 | |
| -1.20 | -0.90 | 0.45 | -0.42 | -0.03 | 0.61 | -0.27 | -0.31 | -0.53 | 0.44 | 0.30 | -0.32 | -0.11 | |
| 0.03 | 0.02 | 0.01 | 0.12 | 0.77 | 0.04 | 0.01 | 0.01 | 0.00 | 0.00 | 0.01 | 0.00 | 0.01 | |
| -1.12 | -0.58 | -0.21 | -3.04 | -2.52 | -2.04 | 0.26 | -0.54 | -17.52 | -0.86 | -4.75 | 14.71 | -6.63 | |
| -0.01 | -0.01 | -0.17 | – | – | – | – | – | -0.74 | 0.00 | – | -2.75 | – | |
| – | – | – | – | 0.00 | 0.00 | 0.00 | 0.00 | 17.19 | 0.33 | 0.00 | 32.06 | 48.25 | |
| 0.19 | 0.35 | 0.67 | 0.53 | 2.99 | 1.07 | -0.24 | 0.75 | 20.31 | 0.39 | -0.71 | 25.02 | 43.52 | |
| -0.49 | 0.21 | 1.50 | -1.77 | 2.47 | 0.46 | -1.27 | 0.99 | 3.56 | 1.68 | -3.01 | 40.83 | 43.00 | |
| 0.41 | 0.38 | 1.03 | 0.62 | 1.21 | 1.46 | -1.34 | 0.78 | 0.65 | 2.17 | 2.44 | 1.10 | 6.02 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 6, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.